BRITISH surgeons say they have carried out remote robotic surgery for the first time. Paul Buxton, 62, had a prostate cancer ...

Radiopharmaceutical developer Telix Pharmaceuticals Ltd (ASX:TLX) is expanding its push into AI-enabled cancer imaging through a new collaboration with Germany’s University Hospital Essen, ...

A large national study in Denmark following nearly 1,900 patients over almost a decade has found that a minimally invasive ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces a research collaboration with University Hospital Essen on the PROMISE-PET registry 1, defining the potential prognostic ...

Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining ...

Trevor Brand has been promoted to CEO of Alta Bates Summit Medical Center in Oakland and Berkeley after leading improvements at another Sutter Health facility in Antioch.

Axogen expects full-year 2026 revenue growth to be at least 18% or total revenue of at least $265.7 million. The company anticipates 2026 gross margin in the range of 74% to 76%, consistent with 2025, ...

Crews are finishing up work to install a new Linear Accelerator (LINAC) at the Jack Ady Cancer Centre in Chinook Regional ...

NHS England has given the green light for abiraterone to be used to treat men with prostate cancer that has not metastasised. It is the first time the drug will be available for these patients in ...

NOVEL research suggests simple blood-based markers could refine MRI use in prostate cancer detection. Magnetic resonance imaging (MRI) has become central to prostate cancer (PCa) diagnostics, ...

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment intensification can meaningfully improve survival for patients with ...